We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2223:TADAWULSaudi Aramco Base Oil Company - Luberef Analysis

Data as of 2026-05-18 - not real-time

HK$1.01

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Casablanca Group Limited is trading at HK$1.01, comfortably above its 20‑day SMA (0.95) and 50‑day SMA (0.92) while still below the 200‑day SMA (0.64), indicating a short‑term bullish bias. Technical momentum is strong with a bullish MACD crossover (line 0.022 > signal 0.015) and rising volume, yet the RSI sits at 71, signalling that the stock is in overbought territory and may face short‑term pressure near the resistance level of 1.05. Fundamentally, the company is struggling: revenue fell 5% YoY, operating and profit margins are negative, and EPS is –0.05, reflecting ongoing profitability challenges. Despite these headwinds, the DCF‑derived fair value of 1.37 suggests the market is pricing in a discount of roughly 25%, and the price‑to‑book ratio of 0.72 points to a potential value opportunity. The balance sheet shows modest debt (DE ratio 4.6) against a solid cash position, and free cash flow remains positive, providing some cushion. Volatility is elevated at 27% over the past 30 days, but beta is low (0.49), indicating limited systematic risk. Investor sentiment is exuberant, as reflected by an “Extreme Greed” reading on the Fear & Greed Index (87). Overall, the stock presents a mixed picture: attractive valuation and technical strength offset by weak earnings and sector cyclicality.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD and rising volume
  • RSI indicating overbought conditions
  • Proximity to technical resistance at 1.05

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value suggests ~25% upside
  • Low beta and solid cash position
  • Potential sector recovery in consumer cyclical space

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Negative earnings trends and margin pressure
  • Undervalued price‑to‑book offering value cushion
  • Need for operational turnaround to sustain growth

Key Metrics & Analysis

Financial Health

Revenue Growth-5.10%
Profit Margin-5.17%
ROE-3.85%
ROA-2.38%
Debt/Equity4.59
P/B Ratio0.7
Op. Cash FlowHK$15.5M
Free Cash FlowHK$17.8M

Technical Analysis

TrendBullish
RSI71.1
SupportHK$0.89
ResistanceHK$1.05
MA 20HK$0.95
MA 50HK$0.92
MA 200HK$0.64
MACDBullish
VolumeIncreasing
Fear & Greed Index87.29

Valuation

Fair ValueHK$1.37
GradeUndervalued
TypeValue

Risk Assessment

Beta0.49
Volatility26.84%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.